Notably, study has suggested that TREM2 + macrophages may promote tumor progression by inhibiting T cell proliferation in other cancer [232], implying that TREM2 + macrophages in ccRCC may also contribute to tumor immune evasion through this mechanism, thereby becoming one of the factors in disease recurrence. This evidence concerns the gene TREM2 and nonpapillary renal cell carcinoma.